US OptionsDetailed Quotes
MARA241213C15000
- 7.59
- -0.66-8.00%
15min DelayClose Dec 13 16:00 ET
7.59High7.59Low
7.59Open8.25Pre Close1 Volume250 Open Interest15.00Strike Price759.00Turnover0.00%IV-0.62%PremiumDec 13, 2024Expiry Date7.73Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma2.93Leverage Ratio--Theta--Rho--Eff Leverage--Vega
MARA Holdings Stock Discussion
Sign in to post a comment
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, Statins are a class of prescription drugs that help lower cholesterol levels. They are the most common treatment for high cholesterol, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drugs and need additional lowering. Over 71 ...
+2
7
1
1
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, Statins are a class of prescription drugs that help lower cholesterol levels. They are the most common treatment for high cholesterol, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drug...
+2
1
2
$MARA Holdings (MARA.US)$ currently forming cup and handle?
1
$MARA Holdings (MARA.US)$ switch to HUT better
1
$MARA Holdings (MARA.US)$ going to breakout let's goooo
1
6
$MARA Holdings (MARA.US)$ Mstr holdings 42k btc, MARA holdings 40k btc and Riot holdings 10k btc as at to date.
What's your thoughts?
What's your thoughts?
1
4
$MARA Holdings (MARA.US)$ clearing 23 that hard?
2
7
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
$MARA Holdings (MARA.US)$ today 28
5
7
No comment yet
10xStockPicks OP : This is the correctly edited research report. Previous article has a few typos. Special thanks to Fund manager John for his notes. Please do your own research. I firmly believe ESPR will be a solid bet.